Clinical Trials

Showing trials with last updates posted in 2024.

NCT03666273 | COMPLETED | PHASE1
60 participants

Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.

Study Type:
INTERVENTIONAL
Last Updated:
2024-05-28
Start Date:
2018-09-12
Completion:
2023-06-16
Conditions
  • Advanced Solid Tumor
  • Head and Neck Squamous Cell Carcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page